Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology A Zimprich, S Biskup, P Leitner, P Lichtner, M Farrer, S Lincoln, ... Neuron 44 (4), 601-607, 2004 | 3517 | 2004 |
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ... Annals of neurology 75 (3), 351-362, 2014 | 719 | 2014 |
Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ... EMBO molecular medicine 4 (5), 380-395, 2012 | 642 | 2012 |
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin N Exner, B Treske, D Paquet, K Holmström, C Schiesling, S Gispert, ... Journal of Neuroscience 27 (45), 12413-12418, 2007 | 624 | 2007 |
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis VM Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J ... Nature Communications, 973, 2019 | 288 | 2019 |
Advances in Parkinson’s disease: 200 years later NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ... Frontiers in neuroanatomy 12, 113, 2018 | 168 | 2018 |
Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ... EMBO molecular medicine 7 (12), 1529-1546, 2015 | 149 | 2015 |
Selective α-synuclein knockdown in monoamine neurons by intranasal oligonucleotide delivery: potential therapy for Parkinson’s disease D Alarcón-Arís, A Recasens, M Galofré, I Carballo-Carbajal, N Zacchi, ... Molecular Therapy 26 (2), 550-567, 2018 | 133 | 2018 |
Leucine-rich repeat kinase 2 induces α-synuclein expression via the extracellular signal-regulated kinase pathway I Carballo-Carbajal, S Weber-Endress, G Rovelli, D Chan, B Wolozin, ... Cellular signalling 22 (5), 821-827, 2010 | 109 | 2010 |
The E3 ubiquitin ligases TRIM17 and TRIM41 modulate α-synuclein expression by regulating ZSCAN21 I Lassot, S Mora, S Lesage, BA Zieba, E Coque, C Condroyer, ... Cell reports 25 (9), 2484-2496. e9, 2018 | 46 | 2018 |
The small GTPase RAC1/CED-10 is essential in maintaining dopaminergic neuron function and survival against α-synuclein-induced toxicity H Kim, C Calatayud, S Guha, I Fernández-Carasa, L Berkowitz, ... Molecular neurobiology 55, 7533-7552, 2018 | 41 | 2018 |
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients A Recasens, I Carballo-Carbajal, A Parent, J Bové, E Gelpi, E Tolosa, ... Acta neuropathologica communications 6, 1-9, 2018 | 31 | 2018 |
Chitinase 3-like 1 is neurotoxic in primary cultured neurons C Matute-Blanch, L Calvo-Barreiro, I Carballo-Carbajal, R Gonzalo, ... Scientific reports 10 (1), 7118, 2020 | 30 | 2020 |
Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology M Vila, A Laguna, I Carballo-Carbajal Autophagy 15 (11), 2028-2030, 2019 | 29 | 2019 |
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol Med 4: 380–395 A Sánchez-Danés, Y Richaud-Patin, I Carballo-Carbajal, ... | 20 | 2012 |
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson’s disease. EMBO Mol Med. 2012; 4 (5): 380–95 A Sánchez-Danés, Y Richaud-Patin, I Carballo-Carbajal, ... Epub 2012/03/13. https://doi. org/10. 1002/emmm. 201200215 PMID: 22407749, 2012 | 14 | 2012 |
Validation of a reversed phase UPLC-MS/MS method to determine dopamine metabolites and oxidation intermediates in neuronal differentiated SH-SY5Y cells and brain tissue M Gonzalez-Sepulveda, A Laguna, I Carballo-Carbajal, ... ACS Chemical Neuroscience 11 (17), 2679-2687, 2020 | 11 | 2020 |
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related multisystem neurodegenerative deficits A Laguna, N Peñuelas, M Gonzalez-Sepulveda, A Nicolau, S Arthaud, ... bioRxiv, 2023.08. 08.552400, 2023 | 1 | 2023 |
Correction to: the small GTPase RAC1/CED-10 is essential in maintaining dopaminergic neuron function and survival against α-synuclein-induced toxicity H Kim, C Calatayud, S Guha, I Fernández-Carasa, L Berkowitz, ... Molecular neurobiology 55, 7553-7554, 2018 | 1 | 2018 |
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits A Laguna, N Peñuelas, M Gonzalez-Sepulveda, A Nicolau, S Arthaud, ... Nature Communications 15 (1), 8819, 2024 | | 2024 |